Presentation TCT 2016 Fully Endovascular Repair Will be the Future of Ascending / Arch Aneurysm Management Presenter: Brian G. DeRubertis, Grayson H. Wheatley November 01, 2016
Presentation TCT 2016 VIDEOTAPED CASE Endovascular Repair of Juxtarenal AAA With Parallel Endograft Technique Presenter: Brian G. DeRubertis, Grayson H. Wheatley, Zvonimir Krajcer November 01, 2016
Presentation TCT 2016 Management of Aneurysmal Dilatation after Type B Dissection: Role of Branched Graft and Fenestrated Devices Presenter: Brian G. DeRubertis, Grayson H. Wheatley, Michael D. Dake November 01, 2016
Presentation TCT 2016 Management of Short-Neck Infra-Renal Aneursyms From Endoanchors to Fenestrated and Chimney Grafts Presenter: Brian G. DeRubertis, Grayson H. Wheatley, Zvonimir Krajcer November 01, 2016
Presentation TCT 2016 Debate: Is Early Endovascular Intervention Appropriate for Uncomplicated Type B Aortic Dissection? Con! Presenter: D. Christopher Metzger, Peter A. Schneider, Rodney White November 01, 2016
Presentation TCT 2016 Debate: Is Early Endovascular Intervention Appropriate for Uncomplicated Type B Aortic Dissection? Pro! Presenter: D. Christopher Metzger, Peter A. Schneider, Christoph A. Nienaber November 01, 2016
Presentation TCT 2016 Bayesian Statistics: Utility and Interpretation Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Marc Etienne Jolicoeur November 01, 2016
Presentation TCT 2016 VIDEOTAPED CASE: Percutaneous EVAR Under Conscious Sedation: Demonstration of Technique and Tips Presenter: D. Christopher Metzger, Peter A. Schneider November 01, 2016
Presentation TCT 2016 Propensity-Matched Analysis: Advantages and Pitfalls Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Tracy Y. Wang November 01, 2016
Presentation TCT 2016 Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Somjot S. Brar November 01, 2016
Presentation TCT 2016 Hypogastric Embolization Is No Longer Necessary in Aorto-iliac EVAR With Contemporary Devices and Techniques Presenter: D. Christopher Metzger, Peter A. Schneider, Brian G. DeRubertis November 01, 2016
Presentation TCT 2016 Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen November 01, 2016
Presentation TCT 2016 Subgroup Analyses: How Useful or Harmful Are They? Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul November 01, 2016
Presentation TCT 2016 Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR Presenter: D. Christopher Metzger, Peter A. Schneider, Barry T. Katzen November 01, 2016
Presentation TCT 2016 Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples) Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber November 01, 2016
Presentation TCT 2016 Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR Presenter: D. Christopher Metzger, Peter A. Schneider, Ehrin J. Armstrong November 01, 2016
Presentation TCT 2016 Use of Intravascular Imaging in CTO Intervention Presenter: Ik-Kyung Jang, Matthew J. Price, Yasushi Asakura October 31, 2016
Presentation TCT 2016 Uses of Physiology and Imaging During Bifurcation Intervention: What Have We Learned and How Should We Apply This Information? Presenter: Ik-Kyung Jang, Matthew J. Price, Bon-Kwon Koo October 31, 2016
Presentation TCT 2016 LM Disease: When to Use FFR, IVUS, or Both Presenter: Ik-Kyung Jang, Matthew J. Price, Gary S. Mintz October 31, 2016
Presentation TCT 2016 Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine Presenter: Emerson C. Perin, Bernard J. Gersh October 31, 2016